A comprehensive plan for managed care of patients infected with Human Immunodeficiency Virus

被引:3
|
作者
Bartlett, JG [1 ]
Moore, R [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
D O I
10.1086/520179
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Medicaid is rapidly moving toward managed care throughout the United States and will have a major impact on care programs for those infected with human immunodeficiency virus (HIV). The experience at the Johns Hopkins HIV Care Service is an example of the transition from fee-for-service to managed care. The Maryland Medicaid program, which has required enrollment of all Medicaid recipients since June 1997, uses an adjusted payment rate and separately funds protease inhibitors. Elements that made the transition to a managed care organization possible included the early development of a comprehensive network of services and a database showing that historical Medicaid payments were low compared with the statewide experience, Our Medicaid managed care program promotes unlimited access to specialists, rejects the "gatekeeper" concept for any service, and includes an open formulary. Nevertheless, it is uncertain that the services now provided can be sustained with anticipated reductions in payments that seem inevitable with Medicaid policies here and nationally.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 50 条
  • [41] Lipodystrophy in human immunodeficiency virus-infected patients
    Chen, DL
    Misra, A
    Garg, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11): : 4845 - 4856
  • [42] Internalized stigma of patients infected with human immunodeficiency virus
    Kirpinar, M. M.
    Yildiz, N.
    Demirel, O. F.
    Yuksel, P. B.
    Balcioglu, I.
    Kocazeybek, B. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S754 - S754
  • [45] Pneumococcal vaccine in patients infected with the human immunodeficiency virus
    Ferrer, VF
    Abad, OL
    Berga, AP
    REVISTA CLINICA ESPANOLA, 2002, 202 (07): : 395 - 398
  • [46] Nocardial infection in patients infected with the human immunodeficiency virus
    Pintado, V
    Gómez-Mampaso, E
    Cobo, J
    Quereda, C
    Meseguer, MA
    Fortún, J
    Navas, E
    Moreno, S
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 716 - 720
  • [47] Hyperhomocysteinemia in human immunodeficiency virus-infected patients
    Duro, M.
    Manso, M. C.
    Rebelo, I
    Medeiros, R.
    Almeida, C.
    BIOMEDICAL RESEARCH-INDIA, 2016, 27 (02): : 557 - 562
  • [48] Nosocomial infections in patients infected with human immunodeficiency virus
    Alfandari, S
    Senneville, E
    Guery, B
    Chidiac, C
    Mouton, Y
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) : 1480 - 1480
  • [49] Plasma homocysteine in human immunodeficiency virus infected patients
    De Larrañaga, G
    Alonso, B
    Puga, L
    Benetucci, J
    MEDICINA-BUENOS AIRES, 2003, 63 (05) : 393 - 398
  • [50] Osteoporosis in human immunodeficiency virus infected patients.
    Medina, F
    Perez, L
    Sartorius, C
    Halabe, J
    Fraga, A
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S203 - S203